Cargando…
Destructive cellular paths underlying familial and sporadic Parkinson disease converge on mitophagy
The knowledge gap separating the molecular and cellular underpinnings of Parkinson disease (PD) and its pathology hinders treatment innovation. Adding to this difficulty is the lack of a reliable biomarker for PD. Our previous studies identify a link of 2 PD proteins, PINK1/PRKN Parkin to a mitochon...
Autor principal: | Wang, Xinnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788483/ https://www.ncbi.nlm.nih.gov/pubmed/28598236 http://dx.doi.org/10.1080/15548627.2017.1327511 |
Ejemplares similares
-
SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease
por: Ivatt, Rachael M, et al.
Publicado: (2014) -
Comment on “mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC”
por: Ganley, Ian G., et al.
Publicado: (2021) -
Two different axes CALCOCO2-RB1CC1 and OPTN-ATG9A initiate PRKN-mediated mitophagy
por: Yamano, Koji, et al.
Publicado: (2020) -
Strengthening the link between mitophagy and Parkinson’s
disease
por: Ganley, Ian G
Publicado: (2022) -
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
por: Giuliano, Sandy, et al.
Publicado: (2023)